NEW YORK (Reuters Health) – Compared with the standard long protocol using gonadotrophin-releasing hormone (GnRH) agonists during ovarian stimulation, the use of GnRH antagonists results in comparable live-birth…
NEW YORK (Reuters Health) – Among MI patients who have undergone successful revascularization, prompt administration of erythropoietin does not reduce ultimate infarct size. In fact, it may have…
NEW YORK (Reuters Health) – Mitral isthmus ablation is a technically challenging procedure and acute subclinical circumflex ‘injury’ following the procedure “is not uncommon,” clinicians from the United…
NEW YORK (Reuters Health) – In ischemic stroke patients weighing more than 100 kg, the fixed maximum dose limit for intravenous recombinant tissue plasminogen activator (rTPA — alteplase)…
NEW YORK (Reuters Health) – Although serum zinc concentration increases in response to intake of a liquid zinc supplement in Senegalese children, this is not the case with…
NEW YORK (Reuters Health) – Among patients seen in the emergency department with chest pain, cardiac CT findings predict their risk for major adverse cardiac events (MACE) in…
NEW YORK (Reuters Health) – When a defective systemic atrioventricular valve needs to be replaced in patients who have corrected transposition of the great arteries, it should be…
NEW YORK (Reuters Health) – There’s now one more reason for statin loading before percutaneous coronary intervention. As well as reducing myocardial damage, high-dose atorvastatin given shortly before…
NEW YORK (Reuters Health) – Clonidine in the form of extended-release tablets improves response to psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder, results of a phase…
NEW YORK (Reuters Health) – In patients with acute MI undergoing percutaneous coronary intervention, routine use of intravascular ultrasound to guide stent placement is not associated with better…
NEW YORK (Reuters Health) – Many patients with acute MI have risk factors for shock, which increase the likelihood of adverse outcomes with early initiation of beta-blocker therapy,…
NEW YORK (Reuters Health) – Ventricular pauses associated with the use of ticagrelor don’t result in clinically significant bradycardia, according to a report in the May 10th Journal…
